NBC Securities Inc. Sells 143 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

NBC Securities Inc. trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.9% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,804 shares of the financial services provider’s stock after selling 143 shares during the period. NBC Securities Inc.’s holdings in iShares Biotechnology ETF were worth $659,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. First Horizon Advisors Inc. raised its holdings in shares of iShares Biotechnology ETF by 5.5% during the fourth quarter. First Horizon Advisors Inc. now owns 2,193 shares of the financial services provider’s stock worth $298,000 after acquiring an additional 115 shares during the period. Pinnacle Wealth Management Advisory Group LLC raised its holdings in shares of iShares Biotechnology ETF by 8.3% during the fourth quarter. Pinnacle Wealth Management Advisory Group LLC now owns 1,931 shares of the financial services provider’s stock worth $262,000 after acquiring an additional 148 shares during the period. Corient Private Wealth LLC raised its holdings in shares of iShares Biotechnology ETF by 1.0% during the fourth quarter. Corient Private Wealth LLC now owns 86,700 shares of the financial services provider’s stock worth $11,778,000 after acquiring an additional 841 shares during the period. Great Valley Advisor Group Inc. raised its holdings in shares of iShares Biotechnology ETF by 14.1% during the fourth quarter. Great Valley Advisor Group Inc. now owns 2,786 shares of the financial services provider’s stock worth $378,000 after acquiring an additional 344 shares during the period. Finally, Premier Path Wealth Partners LLC acquired a new stake in iShares Biotechnology ETF in the 4th quarter valued at $207,000. 62.45% of the stock is currently owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Down 0.8 %

Shares of IBB stock opened at $134.38 on Thursday. iShares Biotechnology ETF has a 1 year low of $111.83 and a 1 year high of $141.16. The firm’s fifty day moving average price is $132.95 and its two-hundred day moving average price is $134.21.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.